FDA Regulatory Pathway Selector
An interactive decision tree for selecting the right FDA regulatory pathway — 510(k), De Novo, PMA, or Exempt — for medical devices.
Starter Prompt
Create an interactive decision tree that helps medical device companies determine whether their device requires a 510(k), De Novo, PMA, or is FDA exempt, based on answers to questions about device class, risk, and predicate devices.
Expanded Prompt
Create a Claude Artifact called the FDA Regulatory Pathway Selector — an interactive step-by-step decision tool built with HTML, CSS, and JavaScript.
Goal
Guide medical device professionals through a structured series of questions to identify the most likely FDA regulatory pathway for their device. Replace the experience of manually reading through CFR parts and FDA guidance documents with a clean, interactive tool.
Audience
Medical device executives, regulatory affairs professionals, product managers, startup founders, and engineers entering the US market for the first time.
The Four Pathways
| Pathway | Description |
|---|---|
| Exempt | Low-risk Class I devices that do not require a premarket submission |
| 510(k) | Substantial equivalence to a legally marketed predicate device |
| De Novo | Novel low-to-moderate risk devices with no valid predicate |
| PMA | High-risk Class III devices requiring clinical evidence of safety and effectiveness |
Decision Tree Logic
Walk users through questions in this sequence:
Step 1 — Device Classification
Is your device a Class I, Class II, or Class III device under 21 CFR?
- I’m not sure → Guide them to the FDA Product Classification Database
- Class I → Go to Step 2
- Class II → Go to Step 3
- Class III → Go to Step 5
Step 2 — Class I Exemption Check
Is your Class I device listed as exempt in 21 CFR Parts 862–892?
- Yes → Result: Exempt (general controls only apply)
- No → Result: 510(k) required
Step 3 — Predicate Device
Does a legally marketed predicate device exist with the same intended use and similar technological characteristics?
- Yes → Go to Step 4
- No → Go to Step 6
Step 4 — Substantial Equivalence
Does your device raise new questions of safety and effectiveness compared to the predicate?
- No → Result: 510(k)
- Yes → Go to Step 6
Step 5 — PMA Exemption Check
Has FDA approved a PMA or Product Development Protocol (PDP) for this device type, or is it reclassified?
- Yes, reclassified to Class II → Go to Step 3
- No → Result: PMA required
Step 6 — De Novo Eligibility
Is your device low-to-moderate risk, and could general and special controls provide reasonable assurance of safety and effectiveness?
- Yes → Result: De Novo request
- No → Result: PMA required
Result Display
For each outcome, show:
- Pathway name (large, prominent)
- Plain-English explanation of what the pathway means
- Typical timeline (e.g., 510(k): 3–12 months; PMA: 1–3+ years)
- Key submission requirements (brief bullet list)
- FDA resource link suggestion (e.g., “Visit FDA’s 510(k) Premarket Notification page”)
- A Start Over button
Design Requirements
- One question displayed at a time — clean, focused, uncluttered
- Progress indicator showing how far through the decision tree the user is
- Large, clear answer buttons
- Smooth transitions between steps
- Professional color palette suited for a regulatory or legal context
- Mobile-friendly
- A Back button on every step
Disclaimer
This tool provides general educational guidance only. Regulatory pathway determinations are complex and fact-specific. Always consult with a qualified regulatory affairs professional or FDA directly before making submission decisions.
Tips for Refining
- “Add a section for EU MDR pathways as a comparison”
- “Add more detail to the De Novo result explaining when it was introduced”
- “Add a summary PDF export of the pathway selected and the answers given”
- “Extend the tree to cover IVD devices under IVDR”